Feb 18 (Reuters) - Swiss generic drug manufacturer Sandoz has agreed to pay $275 million to resolve claims by U.S. consumers and others who accused the company of conspiring with industry rivals ...
Hosted on MSN3mon
Sandoz Agrees on $275 Million Settlement in U.S. Price-Fixing CaseSandoz Group said it would pay $275 million to settle claims from some plaintiffs in a generics drug pricing antitrust lawsuit in the U.S. The Swiss generics-medicine company said Tuesday that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback